期刊文献+

枸橼酸钠用于血液透析导管封管的效果观察 被引量:5

Effect of Sodium Citrate on Tube Sealing of Hemodialysis Catheter
原文传递
导出
摘要 为了探讨枸橼酸钠用于血液透析导管封管的效果,本研究选取2016年1月至2017年8月在我院行血液透析治疗的慢性肾功能不全患者97例,采用随机数字表法将患者随机分为观察组(n=50)和对照组(n=47),观察组给予枸橼酸钠封管,对照组给予肝素钠封管,观察两组封管液堵管率、导管血流量、导管相关性感染发生次数等。本研究结果显示,观察组和对照组3个月内封管液堵管率分别为19.23%和20.95%,差异比较无统计学意义(p>0.05);观察组和对照组导管血流量和导管相关性感染发生次数比较差异无统计学意义(p>0.05);观察组封管后PT和APTT分别为(13.92±3.87)s和(36.08±4.25)s,明显少于对照组(p<0.05),PLT为(149.54±34.44)×10^9/L,明显高于对照组(p<0.05);观察组穿刺压迫点时间、潜血转阴时间和皮肤粘膜出血停止时间分别为(5.42±1.22)min、(4.18±1.03)d和(4.78±1.25)d,明显短于对照组(p<0.05);观察组皮下出血发生率为8.00%,明显低于对照组(p<0.05)。本研究表明,枸橼酸钠用于血液透析导管封管效果与肝素钠相似,但其可明显降低出血倾向,对机体凝血功能影响小。 To investigate the effect of sodium citrate on tube sealing of hemodialysis catheter, 97 patients with chronic renal insufficiency treatedwith hemodialysis in our hospital from January 2016 to August 2017 were selected, and the patients were randomly divided into the observation group (n=50) and the control group (n=47) by random number table. The observation group was sealed with sodium citrate, while the control group was sealed with heparin sodium. The rate of tube blocking, blood flow of catheter, and incidence of catheter related infection and so on of the two groups were observed. The results showed that the sealed tube liquid plugging rate of the observation group and the control group within 3 months were 19.23% and 20.95%, respectively. The difference was not statistically significant (p>0.05). There was no statistically significant difference in the catheter blood flow and the incidence of catheter related infection in the observation group and the control group (p>0.05). The PT and APTT in the observation group after sealing were (13.92±3.87) s and (36.08±4.25) s, respectively, which were significantly less than those in the control group (p<0.05), and PLT was (149.54±34.44)×109/L, which was significantly higher than that in the control group (p<0.05). The puncture pressure time, occult blood clearance time and mucocutaneous bleeding stopping time of observation group were (5.42±1.22) min, (4.18±1.03) d and (4.78±1.25) d, respectively, significantly shorter than the control group (p<0.05). The incidence of subcutaneous hemorrhage in the observation group was 8.00%, which was significantly lower than that of the control group (p<0.05). Therefore, this study showed that the effect of sodium citrate on tube sealing of hemodialysis catheter was similar to that of heparin sodium, but it could obviously reduce the bleeding tendency and had little effect on the body's coagulation function.
作者 汪晶 何燕 Wang Jing;He Yan(College of Nursing, Sichuan College of Traditional Chinese Medicine, Mianyang,621000)
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2018年第12期5609-5615,共7页 Genomics and Applied Biology
基金 四川中医药高等专科学校护理学院资助
关键词 枸橼酸钠 肝素钠 血液透析 封管 Sodium citrate Heparin sodium Hemodialysis Sealing tube
  • 相关文献

参考文献8

二级参考文献74

  • 1戎殳,叶朝阳,孙丽君,陈静,张斌,梅长林.46.7%枸橼酸钠溶液在血液透析患者长期留置导管封管的应用[J].中华肾脏病杂志,2007,23(2):110-112. 被引量:28
  • 2Brophy PD, Somers M J, Baum MA, et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy(CRRT) [ J ]. Nephrol Dial Transplant,2005,20 ( 7 ) : 1416- 1421. 被引量:1
  • 3Uehino S, Bellomo R, Morimatsu H, et al. Continuous renal replace- ment therapy:a worldwide practice survey. The beginning and ending supportive therapy for the kidney ( B. E. S.T. kidney) investigators [J]. Intensive Care Med,2007,33(9) :1563-1570. 被引量:1
  • 4Oudemans-van Straaten HM ,Wester JP,de Pont AC ,et al. Anticoag- ulation strategies in continuous renal replacement therapy:can the choice be evidence based[ J ] ? Intensive Care Med, 2006,32 ( 2 ) : 188-202. 被引量:1
  • 5Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoag- ulation in critically ill patients undergoing continuous renal replace- ment therapy[J]. Intensive Care Med,2012,38 (1) :20-28. 被引量:1
  • 6Wu MY, Hsu YH, Bai CH, et al. Regional citrate versus heparin anti- coagulation for continuous renal replacement therapy:a meta-analysis of randomized controlled trials[J]. Am J Kidney Dis,2012,59(6) : 810-818. 被引量:1
  • 7Betjes MG, van Oosterom D, van Agteren M, et al. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding:similar hemofilter survival but signif- icantly less bleeding [ J ]. J Nephrol, 2007,20 ( 5 ) :602 -608. 被引量:1
  • 8Oudemans-van Straaten HM. Citrate anticoagulation for continuous renal replacement therapy in the critically ill[ J]. Blood Purif,2010, 29(2) :191-196. 被引量:1
  • 9Tovey L, Dickie H, Gangi S, et 81. Beyond the randomized clinical trial : citrate for continuous renal replacement therapy in clinical prac- tice [ J]. Nephron Clin Pract,2013,124 ( 1-2 ) : 119-123. 被引量:1
  • 10Kalb R, Kram R, Morgera S, et al. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk[J]. Ther Apher Dial,2013,17(2) :202- 212. 被引量:1

共引文献105

同被引文献78

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部